Table 1 Parkinson’s data. mean = mean lost worktime reduction, sd = standard deviation, n = sample size
From: The statistical importance of a study for a network meta-analysis estimate
Arm 1 | Arm 2 | Arm 3 | ||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
Study | Treatment | mean | sd | n | Treatment | mean | sd | n | Treatment | mean | sd | n |
1 | placebo | -1.22 | 3.70 | 54 | ropinirole | -1.53 | 4.28 | 95 | ||||
2 | placebo | -0.70 | 3.70 | 172 | pramipexole | -2.40 | 3.40 | 173 | ||||
3 | placebo | -0.30 | 4.40 | 76 | pramipexole | -2.60 | 4.30 | 71 | bromocriptine | -1.2 | 4.3 | 81 |
4 | ropinirole | -0.24 | 3.00 | 128 | bromocriptine | -0.59 | 3.00 | 72 | ||||
5 | ropinirole | -0.73 | 3.00 | 80 | bromocriptine | -0.18 | 3.00 | 46 | ||||
6 | bromocriptine | -2.20 | 2.31 | 137 | cabergoline | -2.50 | 2.18 | 131 | ||||
7 | bromocriptine | -1.80 | 2.48 | 154 | cabergoline | -2.10 | 2.99 | 143 |